Nutraceuticals

Mountain Valley MD Holdings Inc. (MVMD) achieved significant progress in 2025 across its nutraceutical, agriculture, and animal health sectors. Its patented Quicksome™ technology is enhancing nutraceutical product efficacy and development. In agriculture, the Agrarius™ technology demonstrated substantial crop yield increases and improved plant health in trials across various crops and regions. For animal health, MVMD is strategically reviewing its Soluvec™ 1% licensing model to optimize commercialization of its ivermectin formulation.

Forte Group is rebranding to Vanta Holdings (VANTA), pending CSE approval, to unify its beverage and nutraceutical offerings under a premium brand. The company will transition its TRACE product line to VANTA, fortifying brand continuity. Initial shipments to China are anticipated in December 2025, fulfilling modified purchase orders of $2.5 million. Vanta plans U.S. market entry via direct-to-consumer e-commerce for its nutraceuticals. A new CUSIP and ISIN will be obtained and disclosed.